A detailed history of Leeward Financial Partners, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Leeward Financial Partners, LLC holds 51,650 shares of ADPT stock, worth $231,392. This represents 0.1% of its overall portfolio holdings.

Number of Shares
51,650
Previous 51,650 -0.0%
Holding current value
$231,392
Previous $186,000 41.94%
% of portfolio
0.1%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$2.88 - $4.8 $7,047 - $11,745
-2,447 Reduced 4.52%
51,650 $165,000
Q4 2022

Jan 30, 2023

SELL
$6.26 - $9.34 $81,380 - $121,420
-13,000 Reduced 19.37%
54,097 $413,000
Q2 2022

Jul 19, 2022

SELL
$6.4 - $14.73 $9,004 - $20,725
-1,407 Reduced 2.05%
67,097 $543,000
Q1 2022

May 12, 2022

SELL
$10.12 - $28.9 $25,016 - $71,440
-2,472 Reduced 3.48%
68,504 $951,000
Q4 2021

Jan 27, 2022

BUY
$25.17 - $36.85 $1.79 Million - $2.62 Million
70,976 New
70,976 $1.99 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $640M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Leeward Financial Partners, LLC Portfolio

Follow Leeward Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leeward Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leeward Financial Partners, LLC with notifications on news.